Literature DB >> 30666592

Protective Effects of Salidroside on Lead Acetate-induced Oxidative Stress and Hepatotoxicity in Sprague-Dawley Rats.

Chen Chen1, Beibei Lin1, Shanshan Qi2,3, Jia He4, Hongxing Zheng5.   

Abstract

Lead has heavy metal toxicity which endangers human and animal health. Salidroside (SDS) is a natural antioxidant that has extensive pharmacological usage. However, its protective effects on lead-induced oxidative stress and hepatotoxicity has not been reported. In this study, we established an animal model to evaluate the protective effects of SDS on chronic lead exposure induced oxidative stress and hepatotoxicity. Forty healthy Sprague-Dawley (SD) rats were assigned to control group (control, animals were provided with distilled water, n = 10); lead acetate-exposed group (PbAc, animals received lead acetate solution of 500 ppm for 60 days, n = 10); low dosage of SDS-treated group (PbAc-SDS-L, lead acetate exposed animals were given intragastric SDS 150 mg/kg body weight for 60 days, n = 10); and high dosage of SDS-treated group (PbAc-SDS-H, lead acetate exposed animals were given intragastric SDS 300 mg/kg body weight for 60 days, n = 10). The results showed that lead exposure caused a significant increase in serum ALP, AST, ALT, and TB (P < 0.01), and these were reversed after treatment with salidroside for 60 days. Compared to the control, the liver GSH, SOD, and GSH-Px were decreased significantly after lead acetate exposure (P < 0.01). However, after treatment with SDS for 60 days, those were dose-dependently reversed. Similarly, MDA was significantly increased in the PbAc group (P < 0.01), and it was significantly decreased in SDS treatment group. Moreover, SDS ameliorated lead-induced congestion and necrosis of hepatocytes. In addition, the RT-PCR and immunohistochemistry results revealed that the PbAc group showed a significant increase in the protein and mRNA of cytochrome P450 2E1 (CYP2E1) and NADPH oxidase 2 (NOX2) in rat liver. Treatment with SDS significantly reversed CYP2E1 and NOX2 expressions in the liver of lead-exposed rats. The results above indicated that SDS has obvious antioxidant activity; it can cure liver injury caused by lead acetate by inhibiting oxidative stress and increasing the antioxidant stress activity, thus improving the liver tissue structure.

Entities:  

Keywords:  Hepatotoxicity; Lead; Oxidative stress; Salidroside

Year:  2019        PMID: 30666592     DOI: 10.1007/s12011-019-1635-8

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  4 in total

1.  Antagonistic Efficacy of Luteolin against Lead Acetate Exposure-Associated with Hepatotoxicity is Mediated via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activities.

Authors:  Wafa A Al-Megrin; Afrah F Alkhuriji; Al Omar S Yousef; Dina M Metwally; Ola A Habotta; Rami B Kassab; Ahmed E Abdel Moneim; Manal F El-Khadragy
Journal:  Antioxidants (Basel)       Date:  2019-12-21

2.  Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation.

Authors:  Qi Feng; Chen Liu; Wei Gao; Xiao-Ling Geng; Ning Dai
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-27       Impact factor: 3.168

3.  Insight into the Protective Effect of Salidroside against H2O2-Induced Injury in H9C2 Cells.

Authors:  Hui Gao; Xueping Liu; Kunming Tian; Yichong Meng; Cuicui Yu; Yingfu Peng
Journal:  Oxid Med Cell Longev       Date:  2021-11-30       Impact factor: 6.543

4.  Lead exposure-induced changes in hematology and biomarkers of hepatic injury: protective role of TrévoTM supplement.

Authors:  Omotayo B Ilesanmi; Esther F Adeogun; Temitope T Odewale; Bruno Chikere
Journal:  Environ Anal Health Toxicol       Date:  2022-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.